Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$105,000.00
Cardiovascular complications in men treated for clinically-localized prostate cancer: The role of local treatment modality and androgen deprivation therapy
FY 2015-16
Summary
Men with prostate cancer have an increased risk of cardiovascular disease compared to the rest of the population. As prostate cancer treatments including surgery and radiotherapy are effective, cardiovascular diseases may pose a greater risk than prostate cancer for newly diagnosed patients. Previous studies have shown that patients treated with radiotherapy have worse overall survival than patients treated with surgery even though they have the same survival from prostate cancer. In addition to surgery and radiotherapy, patients may receive treatment with androgen-deprivation therapy. Androgen deprivation therapy, by itself, may cause cardiovascular disease. We think that cardiovascular disease caused by prostate cancer treatments (radiotherapy and androgen-deprivation therapy) may explain the worse overall survival for patients treated with radiotherapy.
We are performing a study of all men treated with surgery or radiotherapy for prostate cancer in Ontario between 2002 and 2009. We will find patients treated with surgery and radiotherapy who have similar risks of cardiovascular disease before their prostate cancer treatments. We will then look at whether surgery, radiotherapy and androgen-deprivation therapy affect a patient's chance of developing cardiovascular diseases.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
347931
Name
Wallis Christopher J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - A
Projecttitle
Cardiovascular complications in men treated for clinically-localized prostate cancer: The role of local treatment modality and androgen deprivation therapy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cardiovascular Disease; Epidemiology; Population-Based Cohort Study; Propensity-Score Matching; Prostate Cancer; Radiotherapy; Retrospective Cohort Study; Risk-Adjustment; Surgery
Abstract
Men with prostate cancer have an increased risk of cardiovascular disease compared to the rest of the population. As prostate cancer treatments including surgery and radiotherapy are effective, cardiovascular diseases may pose a greater risk than prostate cancer for newly diagnosed patients. Previous studies have shown that patients treated with radiotherapy have worse overall survival than patients treated with surgery even though they have the same survival from prostate cancer. In addition to surgery and radiotherapy, patients may receive treatment with androgen-deprivation therapy. Androgen deprivation therapy, by itself, may cause cardiovascular disease. We think that cardiovascular disease caused by prostate cancer treatments (radiotherapy and androgen-deprivation therapy) may explain the worse overall survival for patients treated with radiotherapy.
We are performing a study of all men treated with surgery or radiotherapy for prostate cancer in Ontario between 2002 and 2009. We will find patients treated with surgery and radiotherapy who have similar risks of cardiovascular disease before their prostate cancer treatments. We will then look at whether surgery, radiotherapy and androgen-deprivation therapy affect a patient's chance of developing cardiovascular diseases.
Competitiondate
201510
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wallis, Christopher J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~